Adagene Expands Announces Amendment Ti 2021 Collaboration And License Agreement With Exelixis, Under Which Exelixis Will Utilize Adagene's SAFEbody Platform To Generate A Masked Antibody-Drug Conjugate
Author: Benzinga Newsdesk | September 16, 2025 08:07am